Skip to main content

ORIGINAL RESEARCH article

Front. Neurol.

Sec. Neuroepidemiology

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1513390

Prevalence and incidence of multiple sclerosis in Bulgaria

Provisionally accepted
  • Medical University Sofia, Sofia, Bulgaria

The final, formatted version of the article will be published soon.

    Background: Multiple sclerosis (MS) is a chronic, inflammatory, autoimmune, demyelinating and neurodegenerative disease of the central nervous system that primarily affects young, active people and is a leading cause of non-traumatic, irreversible neurological deficit. Multiple sclerosis is one of the most studied diseases in neuroepidemiology and is characterized by an uneven geographical distribution worldwide. Objective: To estimate the prevalence and incidence of multiple sclerosis in Bulgaria and their distribution by age and gender, using data from the latest population census in the country, provided by the National Statistical Institute.Methods: An epidemiological study, covering a 7-year period from 2015 to 2021 was conducted in Bulgaria. Eight regions with their population were included in the study -Blagoevgrad, Montana, Pernik, Svoge, Smolyan, Troyan, Haskovo and Shumen. Data, provided by the National Statistical Institute, were used to calculate the values of prevalence and incidence of multiple sclerosis. All cases were diagnosed using the 2017 McDonald's diagnostic criteria. The results obtained from the study were also used to determine the clinical characteristics of the Bulgarian patient. For the purposes of the epidemiological study an individual questionnaire was developed. Results: On the prevalence day - 07.09.2021, there were 532 people with multiple sclerosis in the studied regions of the country, revealing a prevalence of 121.2/100 000 and an incidence of 4.2/100 000. 182 were males and 350 were females comprising a ratio of 2:1 in favor of the women. More than 50% of all cases had relapsing-remitting course of disease. Secondary-progressive MS had 30% of all patients and 10% suffered from primary progressive multiple sclerosis. Clinically isolated syndrome was present in less than 5% of patients. The mean age at disease onset was 32.2 ± 10.3 years. The established values of prevalence and incidence position Bulgaria in the area with a high frequency of MS. There is an increase in prevalence and incidence compared to previous studies conducted in the country. The results obtained are similar to those reported by the neighboring countries of the Balkan Peninsula and are close to the average values in Europe according to the latest edition of Atlas of Multiple Sclerosis.

    Keywords: Multiple Sclerosis, Epidemiology, Prevalence, Incidence, Bulgaria

    Received: 18 Oct 2024; Accepted: 03 Mar 2025.

    Copyright: © 2025 Nikolova, Milanov and Kmetska. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Antonia Nikolova, Medical University Sofia, Sofia, Bulgaria

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more